The workers’ compensation system works because there is certainty in the amount and type of benefits available. The lack of an authorized treatment for long COVID disrupts that model and leaves employees, employers, and insurance companies with an unpredictable future.
A recent article in Nature discusses why the delay has been so prolonged, especially since the government funding has been enormous. Clinical trials have been slow in moving forward, and the formal approval system has stagnated.
Long COVID has been difficult to identify and has involved multiple major bodily organs. The toll on workers has been enormous and a potential endless wave of claims, both in intensity and duration, faces the workers’ compensation systems nationally.
On the promising side. At least 26 clinical trials are underway, and some progress will be forthcoming to provide adequate treatment that will be effective.
Recommended Citation: Gelman, Jon L., Waiting for a Treatment for Long COVID Creates Uncertainty, Workers' Compensation Blog, Aug. 12, 2022), https://workers-compensation.blogspot.com/2022/08/waiting-for-treatment-for-long-covid.html
Jon L. Gelman of Wayne, NJ, is the author of NJ Workers’ Compensation Law (Thomson-Reuters) and co-author of the national treatise, Modern Workers’ Compensation Law (Thomson-Reuters). For over five decades, the Law Offices of Jon L Gelman 1.973.696.7900 email@example.com have represented injured workers and their families who have suffered occupational accidents and illnesses.
Blog: Workers ' Compensation
LinkedIn Group: Injured Workers Law & Advocacy Group
Author: "Workers' Compensation Law" Thomson-Reuters